Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Time to add?

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on Jan 12, 2021 11:17am

107 Views

Post# 32275864

RE:Time to add?

Hard to tell since we're in a bit of an info vacuum with innuendo's there's more info to come. The long-term case is unchanged except for lower ultimate per share numbers. I have a buy $.20 below market just in case there's a dump. Don't forget everyone's targets need to drop a bit to incorporate this and maybe RBC will piss all over them again, althought I think Abrahams is professional enough not to act that way.

It's a tough one as you can argue it both ways from these levels. I guess if it's below your average cost, can't hurt and we're only talking about more time to get to levels we thought we'd see before if our original thesis's were correct on future values.